Radiology and Oncology · 2016 · 25 citations · 26 references
MedicineOncologyRadiation OncologyClinical Radiation OncologyPalliative MedicineRadiation DosimetryOrgans At RiskPalliative RadiotherapyRadiation TherapyRadiation ToxicityRadiobiological ConsiderationsToxicity GradingBone Marrow AssessmentDose-volume RelationshipOrgan At Risk Dose DistributionPalliative Radiotherapy ToxicityPatient Outcome EvaluationPatient Outcome MeasurementPatient Outcome PredictionRadiation Dose-volume Relationships
BACKGROUND: Radiation-related lymphopenia has been associated with poor patient outcome. Our aim was to identify predictors of lymphopenia after palliative radiotherapy, with a focus on dose-volume parameters. PATIENTS AND METHODS: To retrospectively assess patients with various cancers who had undergone palliative radiotherapy, we delineated three organs at risk: the volume enclosed by the body surface contour (body A), the volume left after excluding air, pleural effusion, ascites, bile, urine, and intestinal content (body B), and the volume of the bone marrow (BM). We then noted the absolute volume of the three organs at risk that had received 5-30 Gy, and assessed the predictive value for post-treatment lymphopenia of grade 3 or higher (LP3+). RESULTS: Of 54 patients, 23 (43%) developed LP3+. Univariate logistic regression analysis showed that body A V5, body A V10, body B V5, body B V10, the number of fractions, and splenic irradiation were significant predictors of LP3+ (p < 0.05). By multivariate analysis, body A V5, body A V10, body B V5, body B V10, and the number of fractions retained significance (p < 0.05). BM dose-volume parameters did not predict lymphopenia. CONCLUSIONS: Higher body A and body B dose-volume parameters and a larger number of fractions may be predictors of severe lymphopenia after palliative radiotherapy.
26
CD4+ follicular helper T cell infiltration predicts breast cancer survival
Chunyan Gu‐Trantien, Sherene Loi, Soizic Garaud et al. · Journal of Clinical Investigation · 2013 · 1.1K citations
Life Sciences, Immunology, Oncology +17
Susannah Yovino, Lawrence Kleinberg, Stuart A. Grossman et al. · Cancer Investigation · 2013 · 408 citations · Full text